Learning Objectives
Upon completion of this activity, participants should be able to:
- Discuss recent clinical trial data supporting earlier initiation of antiretroviral therapy
- Assess the impact of patient-specific factors/comorbidities on the benefits and risks of early antiretroviral therapy initiation when managing newly diagnosed HIV-infected patients
- Apply new data on the optimal timing of antiretroviral therapy initiation in the context of opportunistic infections
- Evaluate recent data on the association between antiretroviral therapy use and HIV transmission risk
- Formulate legal strategies to promote HIV screening, earlier diagnosis, and linkage to care in your clinical practice